Literature DB >> 23384723

Evaluation of MMP2 and Caspase-3 expression in 107 cases of papillary thyroid carcinoma and its association with prognostic factors.

Hiva Saffar1, Sanaz Sanii, Binesh Emami, Ramin Heshmat, Vahid Hagh Panah, Sima Azimi, Seyed Mohammad Tavangar.   

Abstract

Papillary thyroid carcinoma (PTC), including its variants and widely varying behavior, constitutes about 80% of all thyroid malignancies. Increased knowledge regarding molecular alterations has led to attempts to identify diagnostic or prognostic factors for a reliable preoperative approach to the classification of patients according to risk of recurrence. In this study, 107 cases of PTC with known histological properties, including vascular or capsular invasion, were assessed for expression of MMP2 and Caspase-3 using immunohistochemistry. Considering 10% as a cutoff to discriminate cases with invasive behavior from the non-invasive group, there was no relationship between expression of MMP2 or Caspase-3 in tumor cells and the presence of capsular invasion (p=0.45 and 0.64, respectively), as well as for the expression of Caspase-3 and vascular invasion (p=0.43). In case of MMP2, a borderline correlation was found between the positive reaction of tumor cells with the presence of vascular invasion (p=0.05). So the evaluation of MMP2 in thyroid PTC appears to be of some benefit to the prediction of tumor behavior while Caspase-3 as a marker of prediction seems to be of no use.
Copyright © 2012 Elsevier GmbH. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23384723     DOI: 10.1016/j.prp.2012.06.011

Source DB:  PubMed          Journal:  Pathol Res Pract        ISSN: 0344-0338            Impact factor:   3.250


  12 in total

1.  Effect of DAPK1 gene on proliferation, migration, and invasion of carcinoma of pancreas BxPC-3 cell line.

Authors:  Yong Qin; Guan-Xiong Ye; Cheng-Jun Wu; Shi Wang; De-Biao Pan; Jin-Yan Jiang; Jing Fu; Sheng-Qian Xu
Journal:  Int J Clin Exp Pathol       Date:  2014-10-15

2.  An Appraisal of Proliferation and Apoptotic Markers in Papillary Thyroid Carcinoma: An Automated Analysis.

Authors:  Monika Lamba Saini; Caroline Bouzin; Birgit Weynand; Etienne Marbaix
Journal:  PLoS One       Date:  2016-02-10       Impact factor: 3.240

3.  Genetic and Epigenetic of Medullary Thyroid Cancer

Authors:  Fatemeh Khatami; Seyed Mohammad Tavangar
Journal:  Iran Biomed J       Date:  2017-11-11

4.  Circulating Tumor BRAF Mutation and Personalized Thyroidzzm321990Cancer Treatment

Authors:  Fatemeh Khatami; Bagher Larijani; Seyed Mohammad Tavangar
Journal:  Asian Pac J Cancer Prev       Date:  2017-02-01

Review 5.  Current Diagnostic Status of Pheochromocytomaand Future Perspective: A Mini Review.

Authors:  Fatemeh Khatami; Seyed Mohammad Tavangar
Journal:  Iran J Pathol       Date:  2017-07-01

6.  Serum MMP-2 as a potential predictive marker for papillary thyroid carcinoma.

Authors:  Yunpeng Shi; Chang Su; Haixia Hu; He Yan; Wei Li; Guohui Chen; Dahai Xu; Xiaohong Du; Ping Zhang
Journal:  PLoS One       Date:  2018-06-27       Impact factor: 3.240

Review 7.  Circulating tumor DNA (ctDNA) in the era of personalized cancer therapy.

Authors:  Fatemeh Khatami; Seyed Mohammad Tavangar
Journal:  J Diabetes Metab Disord       Date:  2018-03-26

Review 8.  Personalized treatment options for thyroid cancer: current perspectives.

Authors:  Fatemeh Khatami; Bagher Larijani; Shekoufeh Nikfar; Mandana Hasanzad; Kiarad Fendereski; Seyed Mohammad Tavangar
Journal:  Pharmgenomics Pers Med       Date:  2019-09-13

9.  Promoter Methylation of Four Tumor Suppressor Genes in Human Papillary Thyroid Carcinoma.

Authors:  Fatemeh Khatami; Bagher Larijani; Ramin Heshmat; Shirzad Nasiri; Hiva Saffar; Gita Shafiee; Azam Mossafa; Seyed Mohammad Tavangar
Journal:  Iran J Pathol       Date:  2019-09-22

Review 10.  Liquid Biopsy in Thyroid Cancer: New Insight.

Authors:  Fatemeh Khatami; Seyed Mohammad Tavangar
Journal:  Int J Hematol Oncol Stem Cell Res       Date:  2018-07-01
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.